[1]
Y. Ichimura, “Predictive factors for the effect of pirfenidone in idiopathic pulmonary fibrosis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 34, no. 4, pp. 290–299, Feb. 2018, doi: 10.36141/svdld.v34i4.5630.